Back to today’s briefing

Story perspectives

Penn State Cancer Institute Reaccredited for Stem Cell Transplants

2/10/2025

26 6

Summary

Story summary

The Penn State Cancer Institute has proudly earned reaccreditation for stem cell transplantation from FACT, reaffirming its commitment to exceptional cancer care in central Pennsylvania. With over 3,400 successful transplants since 2000, the institute is a beacon of hope, pioneering innovative treatments like CAR T-cell therapy and prioritizing patient safety and well-being.

1 of 1

Story summary

The Penn State Cancer Institute has proudly earned reaccreditation for stem cell transplantation from FACT, reaffirming its commitment to exceptional cancer care in central Pennsylvania. With over 3,400 successful transplants since 2000, the institute is a beacon of hope, pioneering innovative treatments like CAR T-cell therapy and prioritizing patient safety and well-being.